To ask the Secretary of State for Health what steps he is taking to maintain the supply of products for the prevention of a transient ischaemic attack which meet National Institute for Health and Clinical Excellence guidelines.

The Department works closely with manufacturers and other representatives of the medicines supply chain to ensure that patients get the medicines they need, when they need them.

We have no reason to believe that companies supplying the medicines recommended for the treatment and prevention of transient ischaemic attack in accordance with National Institute for Health and Clinical Excellence guidance (aspirin, clopidogrel and modified release dipyridamole) are not able to meet current demand from United Kingdom patients.